PepTalk 2017
PepTalk 2017

Pipeline Five Header

Cambridge Healthtech Institute’s Third Annual
Characterization of Biotherapeutics
Improving Prediction, Screening and Characterization of New Biologics
January 9-10, 2017 | Hilton San Diego Bayfront | San Diego, CA

New biotherapeutics formats are flooding the discovery and development pipelines and with this comes an increasing need for better and faster characterization tools and strategies, and improved biomolecular and biophysical assays for the new biotherapeutics. The Third Annual Characterization of Biotherapeutics conference presents new tools, strategies and case studies on analytical development and characterization of mAbs, ADCs, bispecifics, and other novel protein formats. We are looking for cutting-edge tools, research findings and unpublished data to be featured at this forum.

We invite you to submit a proposal, present a poster and attend to join colleagues in this discussion of the key challenges and solutions improving prediction, screening and characterization of new biologics.

We invite presentation proposals on the following preliminary topics:

  • Analytical characterization, new assays and novel tools for characterization of antibody-drug conjugates (ADCs), bispecifics, multispecifics, oligos, new protein formats and new viral therapeutics
  • Biophysical characterization and property-based molecular design
  • Characterization of conjugation: linker characterization, payload, biophysical testing for binding affinity
  • Physico-chemical method for the prediction of bioactivity, high-throughput immunoassay and biochemical assay
  • Characterization of biodistribution and in vivo fate of biologics: case studies on the correlation between in vitro and in vivo findings
  • Higher-order structure (HOS) characterization in biologics
  • Application of mass spectroscopy for characterization
  • Analytical comparability and biosimilarity
  • Characterization of process impurities, product variants, posttranslational modifications for new biologics and mAbs
  • New tools for sequence variance analysis
  • New developments in high-throughput assays, automation, in-line assays and miniaturized assays

Please click here to submit a speaking proposal for review.

Deadline for submission: May 27, 2016

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, please contact:

Nandini Kashyap
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5406

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470